Search Results - "Gale, Jeremy D"
-
1
A CCR2/5 Inhibitor, PF-04634817, Is Inferior to Monthly Ranibizumab in the Treatment of Diabetic Macular Edema
Published in Investigative ophthalmology & visual science (01-05-2018)“…Ligands for the proinflammatory C-C chemokine receptor types 2 and 5 (CCR2 and CCR5) are elevated in the eyes of patients with diabetic macular edema (DME). We…”
Get full text
Journal Article -
2
Safety and Pharmacokinetics of the Oral TYK2 Inhibitor PF‐06826647: A Phase I, Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Escalation Study
Published in Clinical and translational science (01-03-2021)“…Selective inhibition of tyrosine kinase 2 (TYK2) may offer therapeutic promise in inflammatory conditions, with its role in downstream pro‐inflammatory…”
Get full text
Journal Article -
3
Advantages of a wholly Bayesian approach to assessing efficacy in early drug development: a case study
Published in Pharmaceutical statistics : the journal of the pharmaceutical industry (01-05-2015)“…This paper illustrates how the design and statistical analysis of the primary endpoint of a proof‐of‐concept study can be formulated within a Bayesian…”
Get full text
Journal Article -
4
Human Recombinant Alkaline Phosphatase (Ilofotase Alfa) Protects Against Kidney Ischemia-Reperfusion Injury in Mice and Rats Through Adenosine Receptors
Published in Frontiers in medicine (28-07-2022)“…Adenosine triphosphate (ATP) released from injured or dying cells is a potent pro-inflammatory "danger" signal. Alkaline phosphatase (AP), an endogenous enzyme…”
Get full text
Journal Article -
5
Pregabalin inhibits accelerated defecation and decreased colonic nociceptive threshold in sensitized rats
Published in European journal of pharmacology (15-09-2010)“…Pregabalin, a ligand of α 2δ subunits of voltage-gated calcium channels, reduces visceral hypersensitivity associated with irritable bowel syndrome. However,…”
Get full text
Journal Article -
6
Oral tyrosine kinase 2 inhibitor PF-06826647 demonstrates efficacy and an acceptable safety profile in participants with moderate-to-severe plaque psoriasis in a phase 2b, randomized, double-blind, placebo-controlled study
Published in Journal of the American Academy of Dermatology (01-08-2022)“…Psoriasis treatments lack durable efficacy and have inconvenient administration, highlighting the need for new therapies. To evaluate the efficacy and safety…”
Get full text
Journal Article -
7
A Placebo-controlled Study of PF-06473871 (Anti-Connective Tissue Growth Factor Antisense Oligonucleotide) in Reducing Hypertrophic Skin Scarring
Published in Plastic and reconstructive surgery. Global open (01-09-2018)“…Connective tissue growth factor (CTGF) is a matricellular protein that plays a key role in wound healing and scar formation. Inhibition of CTGF by a specific…”
Get full text
Journal Article -
8
Oral Ritlecitinib and Brepocitinib for Moderate-to-Severe Ulcerative Colitis: Results From a Randomized, Phase 2b Study
Published in Clinical gastroenterology and hepatology (01-09-2023)“…The efficacy and safety of ritlecitinib (oral JAK3/TEC family kinase inhibitor) and brepocitinib (oral TYK2/JAK1 inhibitor) as induction therapy were assessed…”
Get full text
Journal Article -
9
Alternative Endoscopy Reading Paradigms Determine Score Reliability and Effect Size in Ulcerative Colitis
Published in Journal of Crohn's and colitis (27-01-2024)“…Central reading of endoscopy is advocated by regulatory agencies for clinical trials in ulcerative colitis [UC]. It is uncertain whether the local/site reader…”
Get full text
Journal Article -
10
Target Occupancy and Functional Inhibition of JAK3 and TEC Family Kinases by Ritlecitinib in Healthy Adults: An Open-Label, Phase 1 Study
Published in Journal of clinical pharmacology (01-01-2024)“…Ritlecitinib is a small molecule in clinical development that covalently and irreversibly inhibits Janus kinase 3 (JAK3) and the TEC family of kinases (BTK,…”
Get full text
Journal Article -
11
Baseline Serum and Stool Microbiome Biomarkers Predict Clinical Efficacy and Tissue Molecular Response After Ritlecitinib Induction Therapy in Ulcerative Colitis
Published in Journal of Crohn's and colitis (03-09-2024)“…Ritlecitinib, an oral JAK3/TEC family kinase inhibitor, was well-tolerated and efficacious in the phase 2b VIBRATO study in participants with…”
Get full text
Journal Article -
12
Biomarkers of Crohn’s Disease to Support the Development of New Therapeutic Interventions
Published in Inflammatory bowel diseases (01-10-2020)“…Abstract Background Currently, 2 coprimary end points are used by health authorities to determine the effectiveness of therapeutic interventions in patients…”
Get full text
Journal Article -
13
Histological sub‐classification of cirrhosis using collagen proportionate area in patients with chronic hepatitis C
Published in Liver international (01-07-2021)“…Collagen proportionate area (CPA, %) is used to quantify liver fibrosis. Here, we assessed CPA performance to sub‐classify cirrhosis. CPA was measured in…”
Get full text
Journal Article -
14
Effect of PF-04634817, an Oral CCR2/5 Chemokine Receptor Antagonist, on Albuminuria in Adults with Overt Diabetic Nephropathy
Published in Kidney international reports (01-11-2018)“…Inflammatory cell recruitment, which is potentially mediated by the monocyte chemoattractant protein 1/C-C chemokine receptor type 2 (CCR2) system and by C-C…”
Get full text
Journal Article -
15
The use of novel promotility and prosecretory agents for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation
Published in Advances in therapy (01-05-2009)“…Chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (C-IBS) are commonly reported gastrointestinal (GI) disorders that have a…”
Get full text
Journal Article -
16
Alpha 2 Delta (α(2)δ) Ligands, Gabapentin and Pregabalin: What is the Evidence for Potential Use of These Ligands in Irritable Bowel Syndrome
Published in Frontiers in pharmacology (2011)“…Irritable bowel syndrome (IBS) is a complex disorder that is characterized by abdominal pain and altered bowel habit, and often associates with other…”
Get full text
Journal Article -
17
-
18
Evidence for functional ghrelin receptors on parasympathetic preganglionic neurons of micturition control pathways in the rat
Published in Clinical and experimental pharmacology & physiology (01-09-2010)“…Summary 1. Previous work indicates that agonists of ghrelin receptors can act within the spinal cord to stimulate autonomic outputs to the colorectum and to…”
Get full text
Journal Article -
19
-
20